Evidence map›Paper›PMID 25201259›Full record

ArticleThe Journal of allergy and clinical immunology2015

Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.

Tina L Sumpter, Chin H Ho, Anna R Pleet, Olga A Tkacheva, William J Shufesky, Darling M Rojas-Canales, Adrian E Morelli, Adriana T Larregina

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Altered Expression of Substance P and NK1R in CCR3Allergy, asthma & immunology research · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tina L SumpterDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Chin H HoDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Anna R PleetDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Olga A TkachevaDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
William J ShufeskyDepartment of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Darling M Rojas-CanalesDepartment of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Adrian E MorelliDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Adriana T LarreginaDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa; McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pa. Electronic address: adrianal@pitt.edu.
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · US

Funding

Use of Substance P antagonists to regulate the skin immune functionR01AI077511 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LARREGINA, ADRIANA T · 2009 to 2013
$1.8M
NIAID NIH HHS AI077511NIAID NIH HHS R01 AI077511
6 · The paper itself

Abstract

backgroundEfficient development of atopic diseases requires interactions between allergen and adjuvant to initiate and amplify the underlying inflammatory responses. Substance P (SP) and hemokinin-1 (HK-1) are neuropeptides that signal through the neurokinin-1 receptor (NK1R) to promote inflammation. Mast cells initiate the symptoms and tissue effects of atopic disorders, secreting TNF and IL-6 after FcεRI cross-linking by antigen-IgE complexes (FcεRI-activated mast cells [FcεRI-MCs]). Additionally, MCs express the NK1R, suggesting an adjuvant role for NK1R agonists in FcεRI-MC-mediated pathologies; however, in-depth research addressing this relevant aspect of MC biology is lacking.

objectiveWe sought to investigate the effect of NK1R signaling and the individual roles of SP and HK-1 as potential adjuvants for FcεRI-MC-mediated allergic disorders.

methodsBone marrow-derived mast cells (BMMCs) from C57BL/6 wild-type (WT) or NK1R(-/-) mice were used to investigate the effects of NK1R signaling on FcεRI-MCs. BMMCs generated from Tac1(-/-) mice or after culture with Tac4 small interfering RNA were used to address the adjuvancy of SP and HK-1. WT, NK1R(-/-), and c-Kit(W-sh/W-sh) mice reconstituted with WT or NK1R(-/-) BMMCs were used to evaluate NK1R signaling on FcεRI-MC-mediated passive local and systemic anaphylaxis and on airway inflammation.

resultsFcεRI-activated MCs upregulated NK1R and HK-1 transcripts and protein synthesis, without modifying SP expression. In a positive signaling loop HK-1 promoted TNF and IL-6 secretion by MC degranulation and protein synthesis, the latter through the phosphoinositide 3-kinase/Akt/nuclear factor κB pathways. In vivo NK1R signaling was necessary for the development of passive local and systemic anaphylaxis and airway inflammation.

conclusionsFcεRI stimulation of MCs promotes autocrine secretion of HK-1, which signals through NK1R to provide adjuvancy for efficient development of FcεRI-MC-mediated disorders.

Indexed as

Autocrine CommunicationAnaphylaxisAnimalsDisease Models, AnimalFemaleImmunoglobulin EInflammationInterleukin-6LungMast CellsMiceMice, KnockoutReceptors, IgEReceptors, Neurokinin-1Signal TransductionTachykininshemokinin-1Immunoglobulin EInterleukin-6Receptors, IgEReceptors, Neurokinin-1TachykininsTumor Necrosis Factorsairway inflammationFcεRIHemokinin-1IgEIL-6mast cellsneurokinin-1 receptorpassive anaphylaxissubstance PTNF

Identifiers

PMID25201259
PMCPMC4362795
OpenAlexW2141827086

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.